chrX-2797321-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001141919.2(XG):c.334G>A(p.Gly112Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000108 in 1,208,397 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001141919.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XG | NM_001141919.2 | c.334G>A | p.Gly112Ser | missense_variant | 7/11 | ENST00000644266.2 | NP_001135391.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XG | ENST00000644266.2 | c.334G>A | p.Gly112Ser | missense_variant | 7/11 | NM_001141919.2 | ENSP00000494087.1 |
Frequencies
GnomAD3 genomes AF: 0.0000543 AC: 6AN: 110465Hom.: 0 Cov.: 22 AF XY: 0.0000917 AC XY: 3AN XY: 32715
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 182930Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67396
GnomAD4 exome AF: 0.00000638 AC: 7AN: 1097932Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 1AN XY: 363292
GnomAD4 genome AF: 0.0000543 AC: 6AN: 110465Hom.: 0 Cov.: 22 AF XY: 0.0000917 AC XY: 3AN XY: 32715
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 08, 2024 | The c.334G>A (p.G112S) alteration is located in exon 7 (coding exon 7) of the XG gene. This alteration results from a G to A substitution at nucleotide position 334, causing the glycine (G) at amino acid position 112 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at